DARKPOOL0.1.0
AFT-MKT Sign in
ZYBT
Zhengye Biotechnology Holding Limited
NCM Equity
1.52
-0.02 (-1.30%)
52w low 0.6160 8.01 high
12.2% of range
Open
1.53
High
1.55
Low
1.50
Prev Close
1.54
Volume
22.49K
Avg Vol 3M
606.58K
Market Cap
72.03M
Currency
USD

6 Month Trend

full chart ›
— C-- Chg-- Gap-- Vol-- ×avg-- σ-- SMA20-- SMA50-- SMA200-- RSI-- SPY-- DD-- Bench-- Sig-- Hist-- hover · click to pin · ← → step · drag to zoom · shift-drag to measure
2.505.007.50May 26Jun 26Jul 26Aug 26Sep 26Nov 26
—Context
  • Move across the chart.

Company

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CountryChina
Employees269
Website ↗

Performance

change over each horizon
1D -1.30%
5D +10.95%
1M -10.06%
3M -1.94%
6M +58.50%
YTD +32.17%
1Y -28.30%
2Y --
3Y --
5Y --
MAX -66.88%

Technical Rating

910 daily bars
Buy
4 bullish 1 bearish 1 neutral
SignalReading
+ Price vs 50-day average 1.52 vs 1.38
+ Price vs 200-day average 1.52 vs 1.39
− 50-day vs 200-day 1.38 vs 1.39
+ MACD histogram +0.011
+ 3-month rate of change +10.9%
· RSI (14) 58.1 (neutral)

A mechanical summary of past prices only — six indicators, one vote each. It uses no fundamentals, no news and no knowledge of your circumstances, and the signals disagree by design. Not investment advice.

ML Prediction

910 daily bars
HOLD
SignalReading
Predicted next close 1.52
Predicted change -0.77%
Trend UP
Support / Resistance 1.30 / 1.56
Track record 100% of 1 provisional
  • uptrend confirmed

A mechanical fit to past prices, nothing more — no fundamentals, no news, no view of your circumstances. Historically close to a coin flip on direction (see the backtest). Not investment advice.

Valuation

P/E Trailing--
P/E Forward--
Price / Book1.95x
Price / Sales0.63x
EV / EBITDA-3.43x
EPS Trailing-0.20
Dividend Yield0.00%
Beta--

Profitability

Gross Margin20.51%
Operating Margin-77.04%
Net Margin-59.97%
Return on Equity-25.17%
Return on Assets-9.48%
Revenue Growth-40.90%
Debt / Equity0.24x
Current Ratio1.14x

Business

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs. In addition, the company exports its products to Vietnam, Pakistan, and Egypt. It serves direct-end customers, including livestock farmers and local governments; and domestic distributors and exporting distributors. The company was incorporated in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.